Kimelman & Baird’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $321K | Hold |
3,500
| – | – | 0.02% | 102 |
|
|
2026
Q1 | $298K | Hold |
3,500
| – | – | 0.02% | 103 |
|
|
2025
Q4 | $277K | Hold |
3,500
| – | – | 0.02% | 104 |
|
|
2025
Q3 | $280K | Hold |
3,500
| – | – | 0.02% | 105 |
|
|
2025
Q2 | $318K | Hold |
3,500
| – | – | 0.03% | 108 |
|
|
2025
Q1 | $328K | Hold |
3,500
| – | – | 0.03% | 106 |
|
|
2024
Q4 | $318K | Sell |
3,500
-6,000
| -63% | -$573K | 0.03% | 112 |
|
|
2024
Q3 | $986K | Sell |
9,500
-800
| -8% | -$81.5K | 0.08% | 74 |
|
|
2024
Q2 | $1,000K | Buy |
+10,300
| New | +$950K | 0.08% | 69 |
|
|
2021
Q2 | $1.85M | Buy |
+22,800
| New | +$1.86M | 0.17% | 58 |
|
|
2019
Q3 | $1.7M | Hold |
23,100
| – | – | 0.24% | 53 |
|
|
2019
Q2 | $1.66M | Hold |
23,100
| – | – | 0.23% | 54 |
|
|
2019
Q1 | $1.58M | Hold |
23,100
| – | – | 0.23% | 56 |
|
|
2018
Q4 | $1.38M | Hold |
23,100
| – | – | 0.21% | 57 |
|
|
2018
Q3 | $1.55M | Hold |
23,100
| – | – | 0.2% | 57 |
|
|
2018
Q2 | $1.5M | Buy |
+23,100
| New | +$1.51M | 0.2% | 58 |
|
|
2017
Q4 | $1.75M | Buy |
23,130
+30
| +0.1% | +$2.19K | 0.25% | 55 |
|
|
2017
Q3 | $1.68M | Buy |
23,100
+800
| +4% | +$57.7K | 0.25% | 57 |
|
|
2017
Q2 | $1.65M | Hold |
22,300
| – | – | 0.25% | 58 |
|
|
2017
Q1 | $1.63M | Sell |
22,300
-800
| -3% | -$56K | 0.25% | 55 |
|
|
2016
Q4 | $1.51M | Buy |
23,100
+800
| +4% | +$54.9K | 0.25% | 52 |
|
|
2016
Q3 | $1.65M | Hold |
22,300
| – | – | 0.29% | 53 |
|
|
2016
Q2 | $1.63M | Hold |
22,300
| – | – | 0.3% | 53 |
|
|
2016
Q1 | $1.57M | Hold |
22,300
| – | – | 0.29% | 54 |
|
|
2015
Q4 | $1.49M | Buy |
+22,300
| New | +$1.48M | 0.28% | 59 |
|
|
2015
Q2 | $1.46M | Hold |
22,300
| – | – | 0.25% | 64 |
|
|
2015
Q1 | $1.55M | Sell |
22,300
-300
| -1% | -$20.7K | 0.28% | 63 |
|
|
2014
Q4 | $1.56M | Hold |
22,600
| – | – | 0.28% | 63 |
|
|
2014
Q3 | $1.47M | Sell |
22,600
-800
| -3% | -$52.8K | 0.28% | 64 |
|
|
2014
Q2 | $1.59M | Hold |
23,400
| – | – | 0.28% | 64 |
|
|
2014
Q1 | $1.52M | Hold |
23,400
| – | – | 0.28% | 59 |
|
|
2013
Q4 | $1.53M | Hold |
23,400
| – | – | 0.29% | 62 |
|
|
2013
Q3 | $1.39M | Hold |
23,400
| – | – | 0.28% | 62 |
|
|
2013
Q2 | $1.34M | Buy |
+23,400
| New | +$1.39M | 0.28% | 62 |
|
Other funds holding CL
Kimelman & Baird's CL Position: Q2 2026 in Review
Kimelman & Baird held its Colgate-Palmolive (CL) position steady in Q2 2026 at 3,500 shares worth $321K. The position accounts for 0.02% of the portfolio, ranked #102.
Kimelman & Baird first reported a position in CL in Q2 2013 and has held it in 34 quarters since. The position peaked at $1.85M in Q2 2021. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Kimelman & Baird held 3,500 shares of Colgate-Palmolive worth $321K as of Q2 2026.
- Kimelman & Baird left its Colgate-Palmolive share count unchanged in Q2 2026.
- Colgate-Palmolive made up 0.02% of Kimelman & Baird's portfolio in Q2 2026, its #102 holding.
- Kimelman & Baird first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 34 quarters since.
- Kimelman & Baird's Colgate-Palmolive position peaked at $1.85M in Q2 2021.
- 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Kimelman & Baird's 13F filing for Q2 2026, filed 5 Aug 2026.